✦ LIBER ✦

Lessons Learned from the Clinical Development and Market Authorization of Glybera

✍ Scribed by Bryant, Laura M.; Christopher, Devin M.; Giles, April R.; Hinderer, Christian; Rodriguez, Jesse L.; Smith, Jenessa B.; Traxler, Elizabeth A.; Tycko, Josh; Wojno, Adam P.; Wilson, James M.

Book ID: 120630492
Publisher: Mary Ann Liebert
Year: 2013
Tongue: English
Weight: 449 KB
Volume: 24
Category: Article
ISSN: 2324-8637
DOI: 10.1089/humc.2013.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of PI3K inhibitors: lessons

Development of PI3K inhibitors: lessons learned from early clinical trials

✍ Rodon, Jordi; Dienstmann, Rodrigo; Serra, Violeta; Tabernero, Josep 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 396 KB

Clinical software development for the We

Clinical software development for the Web: lessons learned from the BOADICEA project

✍ Alex P Cunningham, Antonis C Antoniou, Douglas F Easton 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 363 KB

The lessons learned from randomized clin

The lessons learned from randomized clinical trials of GERD

✍ F. Pace; A. Sonnenberg; G. Bianchi Porro 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 669 KB

Lessons learned from studies of the deve

Lessons learned from studies of the development of early melanoma

✍ Toshiaki Saida 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 314 KB

Lessons learned from the development of

Lessons learned from the development of enzyme therapy for Gaucher disease

✍ J. A. Barranger; E. O'Rourke 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 62 KB

Lessons Learned from the saltz and Mayo

Lessons Learned from the saltz and Mayo Clinic Regimens

✍ Edward Chu 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 42 KB